These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 5-hydroxytryptamine and precapillary vessels. Van Nueten JM. Fed Proc; 1983 Feb; 42(2):223-7. PubMed ID: 6295823 [Abstract] [Full Text] [Related]
5. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors. Aono J, Nabata H, Ishizuka N, Sakai K. Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933 [Abstract] [Full Text] [Related]
6. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin. Ogunbiyi PO, Eyre P. Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601 [Abstract] [Full Text] [Related]
9. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin? Vanhoutte PM. J Cardiovasc Pharmacol; 1985 Apr; 7 Suppl 7():S105-9. PubMed ID: 2412025 [Abstract] [Full Text] [Related]
10. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat. Persson B, Gradin K, Pettersson A, Hedner T. J Cardiovasc Pharmacol; 1988 Apr; 11 Suppl 1():S22-4. PubMed ID: 2459509 [Abstract] [Full Text] [Related]
12. Serotonin agonists and antagonists in experimental hypertension. Saxena PR, Bolt GR, Dhasmana KM. J Cardiovasc Pharmacol; 1987 Apr; 10 Suppl 3():S12-8. PubMed ID: 2446059 [Abstract] [Full Text] [Related]
13. Ketanserin: haemodynamic effects and mechanism of action. Schalekamp MA, Woittiez AJ, Wenting GJ, van den Meiracker AH, Man in 't Veld AJ. J Hypertens Suppl; 1986 Apr; 4(1):S7-12. PubMed ID: 2871144 [Abstract] [Full Text] [Related]
14. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients. Amery A, Fagard R, Fiocchi R, Lijnen P, Staessen J, Vermylen J. J Cardiovasc Pharmacol; 1984 Apr; 6(1):182-5. PubMed ID: 6199602 [Abstract] [Full Text] [Related]
15. Ketanserin: systemic and regional hemodynamic characterization of its serotonergic and alpha-adrenergic receptor blocking effects in the pithed SHR. Scalbert E, Richer C, Giudicelli JF. J Cardiovasc Pharmacol; 1989 Jan; 13(1):94-104. PubMed ID: 2468942 [Abstract] [Full Text] [Related]
16. Evidence for an alpha-1 receptor-mediated central sympathoinhibitory action of ketanserin. McCall RB, Schuette MR. J Pharmacol Exp Ther; 1984 Mar; 228(3):704-10. PubMed ID: 6323678 [Abstract] [Full Text] [Related]
17. Effects of antagonists of 5-hydroxytryptamine on blood pressure in the anesthetised spontaneously hypertensive rat. Docherty JR, Warnock P. J Cardiovasc Pharmacol; 1987 Mar; 10 Suppl 3():S59-61. PubMed ID: 2446073 [Abstract] [Full Text] [Related]
18. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats. Kalkman HO, Engel G, Hoyer D. J Hypertens Suppl; 1984 Dec; 2(3):S143-5. PubMed ID: 6599662 [Abstract] [Full Text] [Related]